H.R. 1922

Summary

H.R. 1922, the Ensuring Access to Essential Drugs Act, was introduced in the House on Mar 6, 2025 by Rep. Andrew Garbarino (R) with 2 co-sponsors. It was referred to Energy And Commerce, and last saw action on Mar 6, 2025: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Record

Text

H.R. 1922 has 2 co-sponsors.

119 HR 1922 IH: Ensuring Access to Essential Drugs Act
 U.S. House of Representatives
 2025-03-06
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
 I  119th CONGRESS  1st Session  H. R. 1922  IN THE HOUSE OF REPRESENTATIVES   March 6, 2025   Mr. Garbarino  (for himself,  Mrs. Harshbarger , and  Mr. Suozzi ) introduced the following bill; which was referred to the  Committee on Energy and Commerce , and in addition to the Committee on  Ways and Means , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned   A BILL
To amend title XVIII of the Social Security Act to exempt certain drugs from the part D manufacturer discount program under the Medicare program.
1.
Short title
This Act may be cited as the   Ensuring Access to Essential Drugs Act  .
2.
Exempting certain drugs from the part D manufacturer discount program under the Medicare program
Section 1860D–14C(g)(2) of the Social Security Act (42 U.S.C. 1395w–114c(g)(2)) is amended—
(1)
in subparagraph (A), by striking  and  at the end;
(2)
in subparagraph (B), by striking the period and inserting  ; and ; and
(3)
by adding at the end the following new subparagraph:
(C)
does not include an orally administered drug—
(i)
for which a new drug application was approved under section 505 of the Federal Food, Drug, and Cosmetic Act; and
(ii)
that has been granted a narrow exception permitting reclassification as a noninnovator multiple source drug under the Medicaid drug rebate program by the Centers for Medicare & Medicaid Services.
 .

Tracker

The tracker indicates the progress of this legislation as it moves through the legislative process.

CRS Summary

The summaries are the Congressional Research Service’s, one per stage. Read them in full.

Sponsors

Rep. Andrew Garbarino (R) sponsors H.R. 1922, and 2 members have co-sponsored it, all of them from the day it was introduced.

Andrew Garbarino

Rep. · R–NY-2 · Sponsor

Introduced Mar 6, 2025

Diana Harshbarger

Rep. · R–TN-1 · Co-sponsor

Joined Mar 6, 2025 · Original

Thomas Suozzi

Rep. · D–NY-3 · Co-sponsor

Joined Mar 6, 2025 · Original

Show 3 of 3 rows

PreviousNext

Committees

H.R. 1922 went before 2 committees: Ways and Means and Energy and Commerce.

Ways and Means

Ways and Means

Referred To · Mar 6, 2025 · 1,160 Bills

Energy and Commerce

Energy and Commerce

Referred To · Mar 6, 2025 · 1,636 Bills

Actions

H.R. 1922 has taken 2 actions since Mar 6, 2025.

Votes

H.R. 1922 has not gone to a roll call.

Titles

H.R. 1922 goes by 3 titles, 1 of them short titles.

• Ensuring Access to Essential Drugs Act — Display Title
• Ensuring Access to Essential Drugs Act — Short Title(s) as Introduced
• To amend title XVIII of the Social Security Act to exempt certain drugs from the part D manufacturer discount program under the Medicare program. — Official Title as Introduced

Lobbying

1 client hired 1 firm and 7 registered lobbyists who named H.R. 1922 in 1 quarterly filing, 2026. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.

Filed under Budget/Appropriations, Defense, Science/Technology, Trade (domestic/foreign).

Clients

Who paid to be heard, by how many filings named the bill.

Firms

Registrants who filed on the bill, by filings.

Lobbyists

Named on the filings that cite the bill.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.

Classification

The Congressional Research Service files H.R. 1922 under Health, one of its 31 policy areas.

CRS Subjects

CRS assigns every bill one policy area from its 31; H.R. 1922’s is Health.

Source: congress.gov · legiscan.com